AF
FLGT icon

Allworth Financial’s Fulgent Genetics FLGT Stock Holding History

Allworth Financial’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$24.6K Buy
1,201
+1,019
+560% +$17.3K ﹤0.01% 3028
2026
Q1 		$2.89K Buy
182
+110
+153% +$2.39K ﹤0.01% 4224
2025
Q4 		$1.89K Hold
72
– – ﹤0.01% 4141
2025
Q3 		$1.63K Buy
+72
New +$1.48K ﹤0.01% 4097
2024
Q4 		– Sell
-63
Closed -$1.37K – 3979
2024
Q3 		$1.37K Hold
63
– – ﹤0.01% 3109
2024
Q2 		$1.38K Sell
63
-492
-89% -$10.3K ﹤0.01% 3057
2024
Q1 		$12K Buy
555
+5
+0.9% +$124 ﹤0.01% 2030
2023
Q4 		$15.9K Buy
550
+520
+1,733% +$13.9K ﹤0.01% 1766
2023
Q3 		$803 Hold
30
– – ﹤0.01% 2914
2023
Q2 		$1.11K Sell
30
-486
-94% -$16.9K ﹤0.01% 2697
2023
Q1 		$16.1K Buy
516
+501
+3,340% +$16.1K ﹤0.01% 1584
2022
Q4 		$447 Buy
15
+8
+114% +$286 ﹤0.01% 2662
2022
Q3 		$0 Sell
7
-1
-13% -$50 ﹤0.01% 2800
2022
Q2 		$0 Buy
+8
New +$440 ﹤0.01% 2523

Other funds holding FLGT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Allworth Financial's FLGT Position: Q2 2026 in Review

Allworth Financial increased its Fulgent Genetics (FLGT) stake by 560% in Q2 2026, buying an estimated $17.3K and bringing the position to 1,201 shares worth $24.6K. The position accounts for ﹤0.01% of the portfolio, ranked #3028.

Allworth Financial first reported a position in FLGT in Q2 2022 and has held it in 14 quarters since. 142 funds tracked by Wall St. Rank hold FLGT as of Q2 2026.

  • Allworth Financial held 1,201 shares of Fulgent Genetics worth $24.6K as of Q2 2026.
  • Allworth Financial bought 1,019 Fulgent Genetics shares in Q2 2026, an estimated $17.3K.
  • Fulgent Genetics made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #3028 holding.
  • Allworth Financial first reported a position in Fulgent Genetics in Q2 2022 and has held it in 14 quarters since.
  • 142 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.